Association of triglyceride to high density lipoprotein ratio with global cardiac microcalcification to evaluate subclinical coronary atherosclerosis in non-diabetic individuals.
NaF
PET/CT
Triglyceride
cardiac microcalcification
high density lipoprotein
Journal
American journal of cardiovascular disease
ISSN: 2160-200X
Titre abrégé: Am J Cardiovasc Dis
Pays: United States
ID NLM: 101569582
Informations de publication
Date de publication:
2020
2020
Historique:
received:
21
05
2020
accepted:
03
07
2020
entrez:
14
9
2020
pubmed:
15
9
2020
medline:
15
9
2020
Statut:
epublish
Résumé
Triglycerides (TG) to high density lipoprotein (HDL) ratio has been proposed as a marker of insulin resistance and atherosclerosis. We hypothesize that TG/HDL ratio correlates positively with global cardiac microcalcification as assessed by NaF-PET/CT as a surrogate marker for coronary atherosclerosis in healthy non-diabetic individuals. We identified 68 healthy, non-diabetic individuals (age 41.7 ± 13.5 years; 35/33 female/male) from the CAMONA trial. All underwent PET/CT imaging 90 minutes after NaF injection (2.2 Mbq/Kg). Global cardiac average SUVmean (aSUVmean) was calculated by a trained physician for each individual. Fasting plasma lipid profile (total cholesterol (TC), low-density lipoprotein (LDL), HDL, and TG) and fasting plasma glucose were recorded. TG/HDL ratio was calculated for every individual. Univariate and multivariate linear regression models were used to assess the association between TG/HDL ratio and global cardiac aSUVmean. On univariate analysis, there was a positive linear association of TG/HDL ratio and global cardiac aSUVmean (r=0.244, B=0.047, P=0.045). On multivariate analysis adjusted for age, gender, systolic blood pressure, diastolic blood pressure, smoking status, total cholesterol, low-density lipoprotein, and fasting plasma glucose, TG/HDL ratio was found to be independently associated with global cardiac aSUVmean (B=0.060, 95% CI: 0.007-0.114, P=0.027). There was a positive correlation between TG/HDL ratio with global cardiac microcalcification assessed by NaF-PET/CT imaging.
Types de publication
Journal Article
Langues
eng
Pagination
241-246Informations de copyright
AJCD Copyright © 2020.
Déclaration de conflit d'intérêts
None.
Références
Clin Chem. 2010 Jun;56(6):967-76
pubmed: 20431054
J Atheroscler Thromb. 2013;20(2):195-203
pubmed: 23076217
Eur J Nucl Med Mol Imaging. 2020 Jul;47(7):1678-1687
pubmed: 31734781
Curr Cardiol Rep. 2013 Sep;15(9):400
pubmed: 23881582
Circulation. 2019 Mar 5;139(10):e56-e528
pubmed: 30700139
Eur J Nucl Med Mol Imaging. 2017 Feb;44(2):249-258
pubmed: 27796543
Can J Cardiol. 2001 Aug;17(8):859-65
pubmed: 11521128
J Am Coll Cardiol. 2019 Jun 25;73(24):3168-3209
pubmed: 30423391
Curr Opin Lipidol. 2010 Aug;21(4):305-11
pubmed: 20531184
Clinics (Sao Paulo). 2008 Aug;63(4):427-32
pubmed: 18719750
Clin Biochem. 2001 Oct;34(7):583-8
pubmed: 11738396
Diabetes Care. 2005 Jan;28(1):101-7
pubmed: 15616241
Semin Nucl Med. 2018 Nov;48(6):488-497
pubmed: 30322475
Clin Chem. 2003 Nov;49(11):1873-80
pubmed: 14578319
Cir Cir. 2011 Mar-Apr;79(2):126-31
pubmed: 21631973
Eur J Nucl Med Mol Imaging. 2020 Jun;47(6):1538-1551
pubmed: 31773235
Am Heart J. 2009 Mar;157(3):548-55
pubmed: 19249427
Nucl Med Commun. 2017 Nov;38(11):1007-1014
pubmed: 28877084
JAMA Cardiol. 2016 Sep 1;1(6):692-9
pubmed: 27487401
J Atheroscler Thromb. 2018 Apr 1;25(4):294-303
pubmed: 29238011